flibanserin

None of My Business

Detail of FLCL episode 3, 'Marquis de Carabas'.

Do what you’re gonna do: Roll your eyes, groan, gnash your teeth, bang your head on the desk, throw your hands and declare, “I could have guessed that!”

If you happen to be a woman interested in taking Addyi, the first FDA-approved drug intended to treat low libido in women, your doctor will first tell you this: You absolutely cannot drink — at all — as long as you’re taking the drug, because alcohol has been shown to exacerbate its side effects, including fainting, dizziness, and low blood pressure. When the drug hits the market in mid-October, it will come with a black box underlining the importance of abstaining from alcohol while taking the medication.

But here’s the thing. Nobody actually even knows what would happen if a woman taking Addyi were to cheat and have, say, a glass of wine with dinner — because the research on the effects of drinking while on the medication was done almost entirely on men. The alcohol-safety study included 23 men, and a grand total of two women.

(Dahl)

Okay, so: The good news is that there is a reason this happens, and it is perfectly understandable. The bad news is that this doesn’t actually help anything, and thus doesn’t count as good news.

(more…)

Some Words About Something I Know Nothing About

Detail of frame from Panty and Stocking with Garterbelt, episode 8, '… Of the Dead'.

This is one of those I should simply steer clear of.

Critics, on the other hand, point out the teensy problem that the pharmaceutical company’s own drug trials have shown that Addyi (the brand name for flibanserin) doesn’t actually work all that well. The drug, which will likely be available to consumers in mid-October, is a daily medication, and has been associated with some decidedly unsexy side effects, such as dizziness, sleepiness, nausea, insomnia, and dry mouth. Alcohol exacerbates the side effects, so women taking Addyi are told to abstain from drinking as long as they’re taking it. And the payoff is modest at best: In clinical trials involving about 2,400 healthy, pre-menopausal women (their average age was 36), the women taking flibanserin reported up to one more “satisfying sexual event” per month on average, compared with the women who took a placebo.

(Dahl)

After all, if ever there is a time to hide behind being … oh, right. Anyway, yeah, it’s after a paragraph like that, something, something, mumble, murmur, I’ll just shut up now.

(more…)